Drug News

Five-day dosing regimen for Dacogen approved for myelodysplastic syndromes (MDS)

March 12, 2010

The FDA has approved a five-day dosing regimen for Dacogen (decitabine for injection, from Eisai) to treat patients with myelodysplastic syndromes (MDS).
 

Trelstar 22.5mg approved for palliative treatment of prostate cancer

March 11, 2010

The FDA has approved Trelstar 22.5mg (triptorelin pamoate for injectable suspension, from Watson) for the palliative treatment of advanced prostate cancer.
 

Botox approved for upper limb spasticity

March 10, 2010

The FDA has approved Botox (onabotulinumtoxin A, from Allergan) for the treatment of spasticity in the flexor muscles of the elbow, wrist, and fingers in adults.
 

Drug Safety Alerts and Recalls

FDA reviews atypical subtrochanteric femur fractures risk with oral bisphosphonates

March 11, 2010

The FDA has notified healthcare professionals and patients that at this point, the data that have been reviewed have not shown a clear connection between bisphosphonate use and a risk of atypical subtrochanteric femur fractures.
 

FDA warns of intravascular hemolysis risk with WinRho SDF

March 10, 2010

The FDA, Cangene, and Baxter have notified healthcare professionals that cases of intravascular hemolysis (IVH) and its complications have been reported in patients treated for immune thrombocytopenic purpura (ITP) with WinRho SDF [Rho(D) immune globulin IV (human)].
 

New Product of the Week

VICTOZA

 

Family Practice News from Healthday

Daily Family Practice News

Conference News

Round-up



Alternative Medicine Update

Pomegranate packs a powerful punch

Sherril Sego, FNP-C, DNP March 01, 2010

The juice of the pomegranate provides abundant antioxidants and has potential as an anticarcinogenic and anti-inflammatory.
 

Grape seed beneficial in fight against cancer and heart disease

Sherril Sego, MSN, FNP. January 29, 2010

Considering the health benefits of drinking red wine, it's not surprising to learn that grape seeds may contain significant levels of antioxidants.
 

Pharmacist Courses on mycme.com

Course:Rhinitis: Comparing Optimal TreatmentsNew Drug Review from MPR (Quarter 1, 2010)
Credit:2.00 / CE for Pharmacists 1.00 / AMA PRA Category 1 Credit
1.00 / CE for Pharmacists
Profession:PharmacistsPharmacists, Physicians
Expires:3/1/201112/31/2010
Start now!Start now!

How important are herbals and supplements
to your practice?

Please take this short survey

and let us know.

Pharmacist Jobs

Click here for RSS Feed

COLORECTAL CANCER AWARENESS MONTH


This March, MPR is honoring
Colorectal Cancer Awareness Month
with a special drug information newsletter containing state-of-the-art information on the diagnosis, treatment, and prevention for colorectal cancer, as well as intriguing new research

View this month's MPR Seasonal Spotlight

Subscribe to the MPR Seasonal Spotlight

FDA Video

Top 25 Searched Drugs

  1. Glucophage
  2. Prinivil
  3. Lipitor
  4. Zithromax
  5. Zyrtec
  6. Diovan
  7. Flonase
  8. Norvasc
  9. Prednisone
  10. Ultram
  1. Cipro
  2. Tenormin
  3. Crestor
  4. Monodox
  5. Keflex
  6. Lexapro
  7. Paxil
  8. Wellbutrin
  9. Nexium
  10. NitroStat
  11. Advair Diskus
  12. Flomax
  13. Tylenol
  14. Zocor
  15. Zoloft